Literature DB >> 15581904

Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.

Armando Rojas1, Miguel A Morales.   

Abstract

The formation of advanced glycation end-products (AGEs), also called the Maillard reaction, occurs ubiquitously and irreversibly in patients with diabetes mellitus, and its consequences are especially relevant to vascular dysfunctions. The interaction of AGEs with their receptors (RAGE) has been implicated in the development of vascular complications. This interaction elicits remarkable vascular cell changes analogous to those observed in diabetes mellitus, including angiogenic and thrombogenic responses of endothelial cells, increased oxidative stress, and functional alterations in vascular tone control. This review focuses on AGEs formation, the interaction with their specific receptors and how the triggered intracellular events determine functional alterations of vascular endothelium. Finally, some potential pharmacological approaches undertaken to circumvent the deleterious effects of AGEs are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581904     DOI: 10.1016/j.lfs.2004.09.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Tanshinone IIA protects against methylglyoxal-induced injury in human brain microvascular endothelial cells.

Authors:  Wen-Jing Zhou; Qi-Feng Gui; Yue Wu; Yun-Mei Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  M2 macrophages do not fly into a "RAGE".

Authors:  Armando Rojas; Carolina Añazco; Paulina Araya
Journal:  Inflamm Res       Date:  2016-10-03       Impact factor: 4.575

Review 3.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 4.  Advanced glycation end products and diabetic retinopathy.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-19

5.  Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.

Authors:  S Satheesan; J L Figarola; T Dabbs; S Rahbar; R Ermel
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus?

Authors:  G Bjelakovic; S Beninati; B Bjelakovic; D Sokolovic; T Jevtovic; I Stojanovic; S Rossi; C Tabolacci; G Kocić; D Pavlovic; Lj Saranac; S Zivic
Journal:  Mol Cell Biochem       Date:  2010-04-20       Impact factor: 3.396

Review 7.  Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

Authors:  Mohammad Imran Khan; Suvasmita Rath; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-05-22       Impact factor: 15.707

8.  Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy.

Authors:  Se-Jung Yoon; Young Won Yoon; Byoung Kwon Lee; Hyuck Moon Kwon; Ki-Chul Hwang; Myunghyun Kim; Woochul Chang; Bum-Kee Hong; Young-Ho Lee; Soon-Jung Park; Pil-Ki Min; Se-Joong Rim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

9.  A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Antonio Convit
Journal:  Psychoneuroendocrinology       Date:  2009-01-24       Impact factor: 4.905

Review 10.  Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.

Authors:  Udeep Chawla; Manoj Kumar Kashyap; Amjad Husain
Journal:  Mol Cell Biochem       Date:  2021-06-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.